Report Categories
View AllRecent Articles
View All
73YearOld With 15 Million 401k May Face 280000 Cumulative RMD Tax Bill
Dropbox CEO Drew Houston Steps Down After 19Year Tenure Transitions to Executive Chairman Role
Oil Prices Reverse Course as Geopolitical Tensions Continue to Drive Market Volatility
ATT CEO Highlights BlueCollar Worker Demand as AI Reshapes US Labor Market
Silver Prices Consolidate in Tight Range as Market Awaits US PCE and GDP Data Amid Stabilizing Real Yields
Taiwan Chip Stocks Rally as Nvidia Unveils 150 Billion Spending Plan Mainland Rivals Decline
PMT Q1 2026 Earnings EPS Misses Estimates Significantly Stock Declines
SWIM Q1 2026 Earnings Surpasses EPS Estimates with 5272 Surprise
Local Bounti Q1 2026 Earnings EPS Beats Estimate Stock Declines on Limited Disclosure
CCEP Q4 2018 Earnings Slight EPS Miss Highlights Cost Pressures
AXIA Q1 2026 Earnings EPS Misses Estimates Shares Slide 234
Gap Inc GAP Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Uptick
cbdMD Inc YCBD Slightly Lower as Stock Hovers Near Key Support at 071
Cognex Corporation CGNX Rallies Over 3 as Shares Bounce From Key Support
Ramaco Resources Senior Notes METCZ Edge Higher in Quiet Session
Gaxosai Inc GXAI Slips 345 as Support at 106 Looms Potential Bounce or Further Weakness
Annovis Bio ANVS Faces Selling Pressure Key Levels in Focus After 76 Decline
External Links
Endurance Technologies IPO Opens on Strong Anchor Investor Interest
Haemonetics Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Rises 57
Dermata Therapeutics DRMA Shares Climb 385 as Stock Tests Key Resistance Levels
BellRing Brands BRBR Q1 2026 Earnings EPS Miss of 565 Triggers Slight Stock Decline
PCB Bancorp Q1 2026 Earnings Strong EPS Beat Belies Quiet Market Reception
FBIN Q1 2026 Earnings Narrow EPS Miss on Flat Revenue as Stock Advances
ICE Q1 2026 Earnings Earnings Beat Estimates on 29 Surprise Shares Edge Higher
PCVX Q1 2026 Earnings Missed Estimates Amid PreRevenue Stage Stock Inches Higher
Littelfuse LFUS Q1 2026 Earnings Earnings Beat Driven by Operational Discipline and Demand Resilience
Indaptus Therapeutics Q4 2025 Earnings EPS Miss Amid Continued RD Investment